Dr. P.J. Flynn Receives Prestigious Honor from Twin Cities Medical Society Foundation


{image_1}Dr. Patrick J. Flynn was selected by the Twin Cities Medical society Foundation Board as this recipient of the 2016 Charles Bolles Bolles-Rogers Award. Dr. P.J. Flynn was nominated by Dr. Joseph Leach on behalf of his colleagues at Minnesota Oncology.

Candidates for this "Physician of Excellence" award are nominated by their colleagues at Twin City area hospitals and/or clinics for achievement or leadership in medicine, contributions to clinical care, teaching and/or research.  This candidate is considered to be an outstanding physician by his or her peers.

In a letter to Dr. Flynn notifying him of the award, Twin Cities Medical Society Foundation Chair Chris Johnson, M.D. and Twin Cities Medical Society CEO Sue Schettle noted: "Twin Cities Medical Society Foundation considers this award to be the single, most prestigious local honor that can be given to a physician by their colleagues."
Dr. P.J. Flynn's honor was recognized at the October Minnesota Oncology Board meeting, and the  Award will be officially presented to Dr. Flynn in November at a physician event.
 
"We congratulate P.J. on this honor in observance of his excellent clinical care and outstanding leadership with cancer research in the Twin Cities over many years," said Minnesota Oncology President Dean Gesme, M.D. 

Minnesota Oncology physicians Joseph Cardamone, M.D. and Burton Schwartz, M.D. are previous Bolles-Rogers Awardees.

Share

Categories

Tags

Recent Posts

#
August 12, 2026

Learn why vaccines are an important part of cancer care, which vaccines may be recommended during treatment, and how to talk with your oncology team about the right timing.

#
July 30, 2026

Learn why staying up to date on recommended vaccines is important during and after cancer treatment, and how your oncology team can help determine the right immunizations for you.

#
July 28, 2026

Learn what makes sarcoma different from other cancers, including common symptoms, how it's diagnosed, and the treatment options available for this rare cancer of the body's connective tissues.